Page 49 - 74_02

VOL. 74 (2), 203-228, 2008 UNA APROXIMACIÓN FARMACOLÓGICA...

(14) WEBSTER, M. K. and DONOGHUE, D. J. (1996): Constitutive activation of fibro-
(15) blast growth factor receptor 3 by the transmembrane domain point mutation
(16) found in achondroplasia. EMBO J. 15: 520-527.
(17) SOROKIN, A.; LEMMON, M. A.; ULLRICH, A. and SCHLESSINGER, J. (1994): Stabi-
(18) lization of an active dimeric form of the epidermal growth factor receptor
(19) by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269:
(20) 9752-9759.
(21) LIEVENS, P. M.; MUTINELLI, C.; BAYNES, D. and LIBOI, E. (2004): The kinase
(22) activity of fibroblast growth factor receptor 3 with activation loop mutations
(23) affects receptor trafficking and signaling. J. Biol. Chem. 279: 43254-43260.
(24) CHO, J. Y.; GUO, C.; TORELLO, M.; LUNSTRUM, G. P.; IWATA, T.; DENG, C. and
(25) HORTON, W. A. (2004): Defective lysosomal targeting of activated fibroblast
(26) growth factor receptor 3 in achondroplasia. Proc. Natl. Acad. Sci. U.S.A. 101:
609-614.
SAHNI, M.; AMBROSETTI, D. C.; MANSUKHANI, A.; GERTNER, R.; LEVY, D. and BA-
SILICO, C. (1999): FGF signaling inhibits chondrocyte proliferation and regu-
lates bone development through the STAT-1 pathway. Genes Dev. 13: 1361-
1366.
MININA, E.; KRESCHEL, C.; NASKI, M. C.; ORNITZ, D. M. and VORTKAMP, A. (2002):
Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte
proliferation and hypertrophic differentiation. Dev. Cell. 3: 439-449.
DAILEY, L.; LAPLANTINE, E.; PRIORE, R. and BASILICO, C. (2003): A network of
transcriptional and signaling events is activated by FGF to induce chondro-
cyte growth arrest and differentiation. J. Cell. Biol. 161: 1053-1066.
MURAKAMI, S.; BALMES, G.; MCKINNEY, S.; ZHANG, Z.; GIVOL, D. and DE CROM-
BRUGGHE, B. (2004): Constitutive activation of MEK1 in chondrocytes causes
Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-defi-
cient mouse phenotype. Genes Dev. 18: 290-305.
YASODA, A.; KOMATSU, Y.; CHUSHO, H.; MIYAZAWA, T.; OZASA, A.; MIURA, M.; KU-
RIHARA, T.; ROGI, T.; TANAKA, S.; SUDA, M.; TAMURA, N.; OGAWA, Y. and NAKAO,
K. (2004): Overexpression of CNP in chondrocytes rescues achondroplasia
through a MAPK-dependent pathway. Nat. Med. 10: 80-86.
WANG, Y.; SPATZ, M. K.; KANNAN, K.; HAYK, H.; AVIVI, A.; GORIVODSKY, M.; PINES,
M.; YAYON, A.; LONAI, P and GIVOL, D. (1999): A mouse model for achondro-
plasia produced by targeting fibroblast growth factor receptor 3. Proc. Natl.
Acad. Sci. U. S. A. 96: 4455-4460.
SEGEV, O.; CHUMAKOV, I.; NEVO, Z.; GIVOL, D.; MADAR-SHAPIRO, L.; SHEININ, Y.;
WEINREB, M. and YAYON, A. (2000): Restrained chondrocyte proliferation and
maturation with abnormal growth plate vascularization and ossification in
human FGFR-3(G380R) transgenic mice. Hum. Mol. Genet. 9: 249-258.
ROZENBLATT-ROSEN, O.; MOSONEGO-ORNAN, E.; SADOT, E.; MADAR-SHAPIRO, L.; SHEI-
NIN, Y.; GINSBERG, D. and YAYON, A. (2002): Induction of chondrocyte growth
arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell. Sci. 115:
553-562.
MONSONEGO-ORNAN, E.; ADAR, R.; FEFERMAN, T.; SEGEV, O. and YAYON, A. (2000):
The transmembrane mutation G380R in fibroblast growth factor receptor 3

227